Characteristics and prognosis of EBV-positive gastric diffuse large B-cell lymphoma
10.3969/j.issn.1000-8179.2016.06.100
- VernacularTitle:EB病毒阳性的胃弥漫大B细胞淋巴瘤特点及预后
- Author:
Lin LIU
;
Zifen GAO
;
Min LI
;
Xiaolong LIU
;
Cuiling LIU
;
Yan LI
- Publication Type:Journal Article
- Keywords:
diffuse large B-cell lymphoma;
gastric neoplasms;
Epstein-Barr virus;
prognosis
- From:
Chinese Journal of Clinical Oncology
2016;43(6):255-259
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To investigate pathological characteristics and prognosis of patients with Epstein-Barr virus (EBV) positive gastric diffuse large B-cell lymphoma (DLBCL). Methods:Through retrospective study, we collected 75 cases of patients with DLBCL that oc-curs in the stomach. The patients were divided into two groups consisting of 60 cases of EBV negative control group and 15 cases of EBV positive group. To analyze the pathological characteristics and prognosis of patients with EBV positive gastric DLBCL, immunohisto-chemical and Epstein-Barr encoding region (EBER) in situ hybridization methods were used to detect Bcl-2, c-myc protein expression, and EBV-encoded RNA (EBER). Results:In certain aspects of clinical manifestations, such as age, gender, and origin, the comparison be-tween EBV-positive and EBV-negative groups had no statistically significant difference. The same results were obtained for Bcl-2 and c-myc protein expression. However, a statistically significant difference (P=0.01) was observed under the R-CHOP regimen where the me-dian overall survival (OS) of the EBV-positive and EBV-negative groups were 15.1 and 31.4 months, respectively. Conclusion:In pa-tients with DLBCL of the stomach, the EBV infection had no obvious effects in terms of clinical manifestation, origin, morphology, and protein expression of tumor cells. EBV-positive DLBCL was not limited to elderly patients. Under the R-CHOP regimen, the prognosis of EBV-positive patients was worse than that of EBV-negative patients.
